Document Detail

Diagnostic trinity: Graves' disease on F-18 FDG PET.
MedLine Citation:
PMID:  17885368     Owner:  NLM     Status:  MEDLINE    
A 31-year-old man underwent a whole-body F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) scan for cancer screening. There was no history of diabetes, thyroid disease, or noticeable exercise before imaging. The results demonstrated diffusely increased uptake of F-18 FDG in the thyroid and thymus. In addition, there was symmetrically increased uptake of F-18 FDG in skeletal muscles, especially in the psoas and limb muscles. The concurrent appearance of these characteristics led to a diagnosis of Graves' disease.
Yen-Kung Chen; Yuh-Feng Wang; Jainn-Shiun Chiu
Related Documents :
7797748 - Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecti...
15374798 - Prognostic value of exercise stress myocardial perfusion imaging in patients with perma...
8331308 - Variations in the size of the ischemic myocardium due to differences in the normal file.
8422718 - False-positive tc-99m sestamibi spect in a patient with left bundle branch block.
11685048 - Disagreement between bedside and laboratory activated partial thromboplastin time and i...
18279038 - Sex-specific effects of handling time on an index of immune activity in zebra finches.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical nuclear medicine     Volume:  32     ISSN:  0363-9762     ISO Abbreviation:  Clin Nucl Med     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-21     Completed Date:  2007-12-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7611109     Medline TA:  Clin Nucl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  816-7     Citation Subset:  IM    
Department of Nuclear Medicine and PET Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Diagnosis, Differential
Fluorodeoxyglucose F18 / diagnostic use*
Graves Disease / radionuclide imaging*
Muscle, Skeletal / radionuclide imaging*
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use
Thymus Gland / radionuclide imaging*
Thyroid Gland / radionuclide imaging*
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  F-18 FDG PET identification of right atrium metastasis from a vesical carcinoma.
Next Document:  Zero ventilation: a transient episode.